ENGLEWOOD, Colo., March 14, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced the publication of a peer-reviewed journal article demonstrating...
Aytu BioScience Completes Successful Warrant Tender Offer and Receives $2.2 Million from Exercise of Warrants
ENGLEWOOD, Colo., March 1, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced the successful completion of its tender offer to amend and...
Aytu BioScience Announces Expansion of U.S. Sales Team to Support Increasing Growth of Natesto Prescriptions and Revenues
Increasing Number of U.S. Territories by 20%ENGLEWOOD, Colo., Feb. 22, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced the expansion of its...
Aytu BioScience Provides Second Quarter Fiscal 2017 Business Update and Financial Results
Product Revenues Increased 77% from Same Quarter in Prior Year; Cash Burn Reduced by 47% from Previous QuarterForecasting Cash Flow Breakeven in ~18 MonthsLive Conference Call and Webcast TODAY at 4:30 p.m. ETENGLEWOOD, Colo., Feb. 9, 2017 -- Aytu BioScience, Inc....
Aytu BioScience Announces Two Presentations at Endocrine Society 2017 Annual Meeting Highlighting Benefits of Natesto® (Testosterone) Nasal Gel in Men
ENGLEWOOD, Colo., Feb. 1, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that two posters demonstrating clinical data for Natesto®...
Aytu BioScience to Provide Fiscal Second Quarter 2017 Business Update
Live Conference Call and Webcast Scheduled for February 9, 2017, at 4:30 p.m. ETENGLEWOOD, Colo., Jan. 31, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology,...
Aytu BioScience to Present at Noble Capital Markets’ 13th Annual Investor Conference
Presentation on Tuesday, January 31st at 1:30 pm ETENGLEWOOD, Colo., Jan. 24, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that Josh...
Aytu BioScience Announces Two Presentations Highlighting Benefits of Natesto® (Testosterone) Nasal Gel in Men at American Urological Association Annual Meeting
ENGLEWOOD, Colo., Jan. 18, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that two posters demonstrating clinical data for Natesto®...
Aytu BioScience to Present at Biotech Showcase 2017 Investor Conference
Presentation on Monday, January 9th at 9:30 AM Pacific TimeENGLEWOOD, Colo., Jan. 4, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that...
Aytu BioScience Launches Asian Distribution Network for Company’s MiOXSYS® System for Male Infertility
Signs Distribution Agreements with Established Medical Distributors in Japan, Korea, Hong Kong, Macau, and IndiaENGLEWOOD, Colo., Dec. 15, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel...